AML Resources

Welcome to the resource centre.

You can filter the resources by topic and category to find those that best match your needs.

Selecting a resource will open the material in a new tab.

Jumbotron image

Filter

close
padlock icon

Sign up or sign in
to access this content

Sign up here

If you have signed up before,
you can simply confirm your email address:

This email address cannot be found Please sign-up here.

UK-VYX-2200162 | November 2022

Footnotes

*High-risk AML is defined as therapy-related AML or AML with myelodysplasia-related changes

ADVERSE EVENTS REPORTING

Adverse events should be reported. For the UK, reporting forms and information can be found at: https://yellowcard.mhra.gov.uk/

For the Republic of Ireland, reporting forms and information can be found at: https://www.hpra.ie/homepage/about-us/report-an-issue

Adverse events should also be reported to Jazz Pharmaceuticals by phone: +44 8081890387 (UK toll-free) or +353 1 968 1631 (Republic of Ireland).

UK-VYX-2200071 | June 2022